SUNITINIB SANDOZ
Capsule, hard, 50mg
RxActive license
Active substance (INN)
sunitinib
Pharmaceutical form
Pharmaceutical formCapsule, hard
Strength50mg
PackagingUkupno 28 kapsula tvrdih u blisteru (7x4) u kartonskoj kutiji
ManufacturerLek farmacevtska družba d.d. (Lek Pharmaceuticals d.d.), Slovenia
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJanuary 31, 2022
Analogs in Montenegro
20Other medicines with the same active substance
FASINDORRestricted
Capsule, hard, 50mgFASINDORRx
Capsule, hard, 12.5mgFASINDORRx
Capsule, hard, 25mgMISVENOLRx
Capsule, hard, 25mgMISVENOLRx
Capsule, hard, 50mgMISVENOLRx
Capsule, hard, 12.5mgSUNITINIB PLIVARestricted
Capsule, hard, 50 mgSUNITINIB PLIVARestricted
Capsule, hard, 25 mgSUNITINIB PLIVARestricted
Capsule, hard, 12.5 mgSUNITINIB SANDOZRx
Capsule, hard, 25mgSUNITINIB SANDOZRx
Capsule, hard, 12.5mgSUNITINIB ZENTIVARx
Capsule, hard, 25mgSUNITINIB ZENTIVARx
Capsule, hard, 50mgSUNITINIB ZENTIVARx
Capsule, hard, 12.5mgSUNITINIB ZENTIVARx
Capsule, hard, 25mgSUNITINIB ZENTIVARx
Capsule, hard, 50mgSUNITINIB ZENTIVARx
Capsule, hard, 12.5mgSUTENTRx
Capsule, hard, 25mgSUTENTRx
Capsule, hard, 50mgSUTENTRx
Capsule, hard, 12.5mgSource: CInMED register